| 68Ga-PSMA PET/CT in Prostate Cancer (NCT04684628) | University of Saskatchewan | 2020-12-09 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief (NCT04177056) | Hamilton Health Sciences Corporation | 2020-12-04 |
| Insulin Resistance Following ADT for Prostate CA (NCT04658849) | St. Louis University | 2020-12-02 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada (NCT00573586) | SonaCare Medical | 2020-12-01 |
| Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging (NCT04698564) | University of Maryland, Baltimore | 2020-12-01 |
| SLPI for Prostate Cancer (NCT04854343) | University of Florence | 2020-12-01 |
| RESIST-ADT (Androgen Deprivation Therapy) (NCT04485767) | Dana-Farber Cancer Institute | 2020-12-01 |
| Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer (NCT02811809) | The University of Texas Health Science Center, Houston | 2020-12-01 |
| Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico (NCT04661176) | miR Scientific LLC | 2020-11-30 |
| Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer (NCT04656678) | Northwell Health | 2020-11-25 |
| Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker (NCT04633148) | AvenCell Europe GmbH | 2020-11-23 |
| Mobile Sensor Technologies to Assess General Symptomology of People With Cancer (NCT04465214) | National Cancer Institute (NCI) | 2020-11-23 |
| Prospective Evaluation of a Commercially Available Hydrogel Spacer (NCT05323747) | BioProtect | 2020-11-20 |
| Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) (NCT04486755) | University of Maryland, Baltimore | 2020-11-19 |
| PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT (NCT05615909) | Odense University Hospital | 2020-11-19 |
| KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice (NCT04763824) | University of Kansas Medical Center | 2020-11-18 |
| Prostate Cancer in Renal Transplants Recipients (NCT04642833) | University of Florence | 2020-11-18 |
| Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic Prostatectomy (NCT04615494) | Asan Medical Center | 2020-11-17 |
| Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin (NCT04536805) | Institut Cancerologie de l'Ouest | 2020-11-17 |
| Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence (NCT04924218) | Ankara Yildirim Beyazıt University | 2020-11-15 |
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
| Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009) (NCT05423431) | BioProtect | 2020-11-09 |
| A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (NCT04194554) | University of Michigan Rogel Cancer Center | 2020-11-06 |
| Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate (NCT03589781) | Nikkei (Canada) Marketing Limited | 2020-11-05 |
| Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer (NCT04396808) | University of Michigan Rogel Cancer Center | 2020-11-05 |
| Re-treatment 225Ac-J591 for mCRPC (NCT04576871) | Weill Medical College of Cornell University | 2020-10-29 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer (NCT04619069) | Sunnybrook Health Sciences Centre | 2020-10-27 |
| Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer (NCT04389918) | Stanford University | 2020-10-26 |
| Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. (NCT04792138) | University College, London | 2020-10-23 |
| PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer (NCT04560725) | Peking University Cancer Hospital & Institute | 2020-10-22 |
| Trial of NanoPac Focal Therapy for Prostate Cancer (NCT04221828) | NanOlogy, LLC | 2020-10-20 |
| Tempus Priority Study: A Pan-tumor Observational Study (NCT05179824) | Tempus AI | 2020-10-19 |
| Jump: MR Simulation For Radiation Therapy Master Protocol (NCT04545957) | Brigham and Women's Hospital | 2020-10-14 |
| 68 Ga-PSMA for High Risk Prostate Cancer (NCT04614363) | The Methodist Hospital Research Institute | 2020-10-13 |
| 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer (NCT04831541) | First Affiliated Hospital of Fujian Medical University | 2020-10-10 |
| A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy (NCT04574401) | Intuitive Surgical | 2020-10-10 |
| Researching the Effect of Exercise on Cancer (NCT04589468) | City of Hope Medical Center | 2020-10-02 |
| Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection (NCT05589558) | I.M. Sechenov First Moscow State Medical University | 2020-10-01 |
| Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone (NCT04296578) | Stanford University | 2020-10-01 |
| Prospective Prostate Cancer and Patient-reported Outcomes Registry (NCT04694924) | Universitaire Ziekenhuizen KU Leuven | 2020-10-01 |
| Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity (NCT04580667) | DiaCarta, Inc. | 2020-10-01 |
| 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients (NCT04796467) | Peking Union Medical College Hospital | 2020-10-01 |
| Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference (NCT03960112) | Institut Paoli-Calmettes | 2020-10-01 |
| Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer (NCT04272645) | University of Michigan Rogel Cancer Center | 2020-10-01 |
| Transpelvic Magnetic Stimulation to Improve Urogenital Function (NCT04488068) | VA Office of Research and Development | 2020-10-01 |
| The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients (NCT06604247) | Abramson Cancer Center at Penn Medicine | 2020-09-30 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer (NCT06709326) | Umeå University | 2020-09-29 |
| Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer (NCT04543799) | Oncology Institute of Southern Switzerland | 2020-09-24 |
| Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks (NCT04422132) | Weill Medical College of Cornell University | 2020-09-24 |
| Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (NCT04557449) | Pfizer | 2020-09-23 |
| Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer (NCT04632251) | Lightpoint Medical Limited | 2020-09-16 |
| Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older. (NCT04535908) | Medical University of Graz | 2020-09-16 |
| PET/MRI to Stage Prostate Cancer Patients (NCT06484361) | IRCCS San Raffaele | 2020-09-09 |
| PROState Pathway Embedded Comparative Trial (NCT04400656) | Imperial College London | 2020-09-08 |
| EXCEL: Exercise for Cancer to Enhance Living Well (NCT04478851) | University of Calgary | 2020-09-02 |
| 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer (NCT04487847) | Radboud University Medical Center | 2020-09-01 |
| Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients (NCT04300673) | Radboud University Medical Center | 2020-09-01 |
| Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients (NCT06690970) | Tianjin Medical University | 2020-09-01 |
| PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC. (NCT07428642) | First Affiliated Hospital of Wenzhou Medical University | 2020-09-01 |
| PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (NCT04642027) | University Medical Center Groningen | 2020-09-01 |
| Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer (NCT04549688) | The Hospital of Vestfold | 2020-09-01 |
| Testing the Effect of Mindfulness for Prostatectomy Outcomes (NCT04727710) | University of Michigan Rogel Cancer Center | 2020-08-26 |
| Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) (NCT04638049) | University Hospital, Ghent | 2020-08-25 |
| Clinical Trial of Green Tea Catechins in Men on Active Surveillance (NCT04300855) | H. Lee Moffitt Cancer Center and Research Institute | 2020-08-21 |
| MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer (NCT04599218) | Ardeshir Rastinehad | 2020-08-21 |
| Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC (NCT04506567) | Weill Medical College of Cornell University | 2020-08-18 |
| Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men (NCT03869216) | Xavier University of Louisiana. | 2020-08-17 |
| Anesthesia in PROstate Biopsy Pain Obstruction Study (NCT04501055) | Shanghai East Hospital | 2020-08-13 |
| Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2) (NCT04228055) | University of Arizona | 2020-08-07 |
| The Impact of Low Pressure Pneumo in RARP II (NCT04394676) | Metro Health, Michigan | 2020-08-04 |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer (NCT04428203) | Zin W Myint | 2020-08-03 |
| Focal Therapy for Localized Prostate Cancer (NCT03970863) | China Medical University Hospital | 2020-08-01 |
| Transperineal Laser Ablation for Focal Treatment of Prostate Cancer (NCT04170478) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-08-01 |
| PSA Glycomics Assay for Early Detection of Prostate Cancer (NCT04393376) | Prof.dr. H.P. Beerlage | 2020-08-01 |
| Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. (NCT04775602) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2020-07-31 |
| Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer (NCT04085991) | Sir Mortimer B. Davis - Jewish General Hospital | 2020-07-31 |
| 2 Ablative RadioTherapy Treatments for Prostate Cancer (NCT04654338) | Sunnybrook Health Sciences Centre | 2020-07-29 |
| Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors (NCT04704804) | Institut Cancerologie de l'Ouest | 2020-07-24 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer (NCT04409288) | Chinese University of Hong Kong | 2020-07-20 |
| Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer (NCT04443062) | Radboud University Medical Center | 2020-07-20 |
| Assessment of VMCore Biopsy Versus Standard of Care Biopsy (NCT04982536) | Uro-1 Medical | 2020-07-19 |
| The Genomic Medicine at VA Study (NCT04331535) | Boston VA Research Institute, Inc. | 2020-07-17 |
| Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer (NCT04346225) | Ivan de Kouchkovsky, MD | 2020-07-16 |
| PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study (NCT04176497) | UNC Lineberger Comprehensive Cancer Center | 2020-07-16 |
| Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial (NCT05188911) | Fudan University | 2020-07-15 |
| A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors (NCT04424641) | Genmab | 2020-07-15 |
| Streaming Web-based Exercise At Home: A Pilot Study (NCT04282967) | Celina Shirazipour | 2020-07-07 |
| Long-term Better Than Short-term ADT With Salvage RT (NCT04242017) | Universitaire Ziekenhuizen KU Leuven | 2020-07-07 |
| Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors (NCT04340245) | University College, London | 2020-07-01 |
| PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy (NCT04369508) | Xuanwu Hospital, Beijing | 2020-07-01 |
| A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors (NCT04478279) | Sapience Therapeutics | 2020-07-01 |
| Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer (NCT04402151) | Weill Medical College of Cornell University | 2020-06-30 |
| Marker Driven Selection of Patients for Prostate Biopsy and Management (NCT04240327) | University of Miami | 2020-06-29 |
| Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer (NCT04421222) | ESSA Pharmaceuticals | 2020-06-23 |
| Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study (NCT03927521) | Hospices Civils de Lyon | 2020-06-23 |